The level of systemic inflammation and the state of central hemodynamics in patients with coronary heart disease with metabolic syndrome
Ескіз недоступний
Дата
2019
Назва журналу
Номер ISSN
Назва тому
Видавець
Анотація
Metabolic syndrome (MS) is one of the possible risk factors for coronary heart disease (CHD) [2,7]. Meanwhile, cardiovascular disease, and first and foremost, CHD, is one of the leading causes of death in developed countries of the world [1,8]. The prognosis for patients with coronary heart disease depends, predominantly, on the progression of coronary atherosclerosis (CA). Clinical significance of MS is
determined by its important prognostic value in the development of cardiovascular diseases (CVD), and in particular, CHD, due to disturbance of the function of endothelial and smooth muscle cells of the vessels, local intravascular inflammation, increased platelets function and thrombosis [4,8]. The achievement of recent years is the concept as to the important role of chronic systemic inflammation (CSI) and
insulin resistance (IR) in the pathogenesis of CA and CHD, which is especially relevant for MS patients [3, 8, 9].
Опис
Ключові слова
Бібліографічний опис
The level of systemic inflammation and the state of central hemodynamics in patients with coronary heart disease with metabolic syndrome / S.V. Shut’, N. I. Chekalina, T. A. Trybrat [et al.] // Biological Markers in Fundamental and Clinical Medicine. – 2019. – № 1. – Р. 93–94.